Evidence map›Paper›PMID 21057870›Full record

ArticleGlycoconjugate journal2010

Involvement of murine β-1,4-galactosyltransferase V in lactosylceramide biosynthesis.

Tadahiro Kumagai, Takeshi Sato, Shunji Natsuka, Yukito Kobayashi, Dapeng Zhou, Tadashi Shinkai, Satoru Hayakawa, Kiyoshi Furukawa

Abstract read
In one paragraph

Article in Glycoconjugate journal, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 50 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Central Roles of Glucosylceramide in Driving Cancer Pathogenesis.International journal of molecular sciences · 2025
    Review
  5. Review
  6. Functional evaluation of novel variants ofFrontiers in neuroscience · 2024
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Gangliosides and Neuroblastomas.International journal of molecular sciences · 2020
    Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Glycosphingolipid-Protein Interaction in Signal Transduction.International journal of molecular sciences · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Tadahiro KumagaiLaboratory of Glycobiology, Department of Bioengineering, Nagaoka University of Technology, Nagaoka, Niigata, 940-2188, Japan.
Takeshi Sato
Shunji Natsuka
Yukito Kobayashi
Dapeng Zhou
Tadashi Shinkai
Satoru Hayakawa
Kiyoshi Furukawa
Nagaoka University of Technology · JPTokyo Metropolitan Institute of Gerontology · JPNagaoka University · JPNiigata University · JPThe University of Texas MD Anderson Cancer Center · US

Funding

Endogenous glycosphingolipid antigens for NKT cellsR01AI079232 · NIAID · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI ZHOU, DAPENG · 2009 to 2013
$1.9M
NIAID NIH HHS R01 AI079232
6 · The paper itself

Abstract

Human β-1,4-galactosyltransferase (β-1,4-GalT) V was shown to be involved in the biosynthesis of N-glycans, O-glycans and lactosylceramide (Lac-Cer) by in vitro studies. To determine its substrate specificity, enzymatic activity and its products were analyzed using mouse embryonic fibroblast (MEF) cells from β-1,4-GalT V (B4galt5)-mutant mice. Analysis of expression levels of the β-1,4-GalT I-VI genes revealed that the expression of the β-1,4-GalT V gene in B4galt5 ( +/- ) - and B4galt5 ( -/- ) -derived MEF cells are a half and null when compared to that of B4galt5 ( +/+ )-derived MEF cells without altering the expression levels of other β-1,4-GalT genes. These MEF cells showed no apparent difference in their growth. When β-1,4-GalT activities were determined towards GlcNAcβ-S-pNP, no significant difference in its specific activity was obtained among B4galt5 ( +/+ )-, B4galt5 ( +/- ) - and B4galt5 ( -/- ) -derived MEF cells. No significant differences were obtained in structures and amounts of N-glycans and lectin bindings to membrane glycoproteins among B4galt5 ( +/+ )-, B4galt5 ( +/- ) - and B4galt5 ( -/- ) -derived MEF cells. However, when cell homogenates were incubated with glucosylceramide in the presence of UDP-[(3)H]Gal, Lac-Cer synthase activity in B4galt5 ( +/- ) - and B4galt5 ( -/- ) -derived MEF cells decreased to 41% and 11% of that of B4galt5 ( +/+ )-derived MEF cells. Consistent with this, amounts of Lac-Cer and its derivative GM3 in B4galt5 ( -/- ) -derived MEF cells decreased remarkably when compared with those of B4galt5 ( +/+ )-derived MEF cells. These results indicate that murine β-1,4-GalT V is involved in Lac-Cer biosynthesis.

Indexed as

AnimalsAntigens, CDCell LineCell ProliferationFibroblastsGalactosyltransferasesGlycolipidsGlycosylationLactosylceramidesMembrane GlycoproteinsMiceMice, Mutant StrainsSubstrate SpecificityAntigens, CDbeta-1,4-galactosyltransferase VCDw17 antigenGalactosyltransferasesGlycolipidsLactosylceramidesMembrane Glycoproteins

Identifiers

PMID21057870
PMCPMC3568439
OpenAlexW1997923211

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.